Health Canada Approves Pfizer Vaccine for Children Aged 5 to 11

A vial of Pfizer-BioNTech COVID-19 vaccine is pictured at an Alberta Health Services vaccination clinic in Didsbury, Alta., on June 29, 2021. The Canadian Press/Jeff McIntosh

Health Canada has announced that the Pfizer-BioNTech COVID-19 vaccine has been approved for children between the ages of 5 and 11, the first vaccine to be used for this age group in the country.

Health officials announced the decision in a press conference on Friday, with the specific timeline of the vaccine rollout to be announced later in the day.